Pharma Marketing 2010 - Frankfurt

North West Business Group30 September 2010, Frankfurt, Germany.
Pharma Marketing 2010 in Frankfurt provides a key platform for Europe's pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key challenges of a price-sensitive and increasingly competitive and rapidly changing market.

This event offers the perfect setting for industry peers to present their ideas and successes directly to key decision makers from leading pharmaceutical companies. At this meeting you will meet and interact with senior level marketing executives, through a number of one-on-one meetings and networking activities.

They will discuss the challenges and strategies used to enhance online communication, customer relationship, strengthen brand awareness and improve profitability in marketing. This is your one-stop-shop to the most up to date online marketing strategies, regulatory low down, measuring ROI, analytical tools and more such as:

  • 5 reasons why Pharma should not do E-marketing
  • The successful commercialisation of a pharma brand start with an effective launch
  • Forecasting is easy, communication is difficult
  • Achieving Launch Excellence in a Challenging Pharma Marketplace
  • The Doctor - Patient - Pharma: a triangle about a patient's health improvement.
  • Balancing "old" and "new" marketing strategies
  • Brand Management
  • Why Online Belongs to the Pharma Marketing Mix

Joins some of the experts like:

  • IMS heath, Director commercial effectiveness EMEA
  • UCB Pharma, Head of eStrategies
  • Novartis Oncology Region Europe, Regional Brand Leader
  • Eli Lilly, Director Human Resources
  • Astellas Pharma,Marketing Director
  • Genzyme, Associate Director Global Commercial Effectiveness and Development
  • AstraZneca, VP Global Marketing
  • Allergan, Director Consumer Marketing
  • Google, Industry Head
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the Pharmaceutical industry: Presidents, Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

For further information and registration, please visit:
http://nwbg.eu/all-events/pharma-marketing-2010/

Most Popular Now

AstraZeneca amends collaboration with Ironwood for…

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess (linaclo...

Cause of antibiotic resistance identified

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patient...

Bayer, Brigham and Women’s Hospital, and Massachus…

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to ...

FDA grants Fast Track designation for Farxiga in h…

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk ...

Amgen announces positive results from two Phase 3 …

Amgen (NASDAQ:AMGN) today announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (2012021...

Brilinta monotherapy in high-bleeding risk patient…

New data from TWILIGHT, a Phase IV independent trial (funded by AstraZeneca), showed that in patients at high-bleeding risk who underwent PCI and completed 3 months of du...

AstraZeneca divests rights for Losec to Cheplaphar…

AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arznei...

Educational campaign helps teens and their caregiv…

Teenagers face many challenges, and growing up with a chronic skin disease called atopic dermatitis (AD) can impact the ups and downs and transitions to young adulthood. ...

Gene-targeted cancer drugs, slow release overcome …

Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, prot...

Ian Read to retire as Executive Chairman of Pfizer…

Following its regularly scheduled meeting, the Board of Directors of Pfizer Inc. (NYSE:PFE) today announced that Executive Chairman of the Board Ian C. Read has chosen to...

Novartis and Microsoft announce collaboration to t…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science pa...

Study points to new drug target in fight against c…

Researchers have identified a potential new drug target in the fight against cancer. In a study this week in the Proceedings of the National Academy of Sciences, an inter...